Prosecution Insights
Prosecution Insights
Technology area: Biotechnology & Pharmaceuticals
2 pending office actions • 1 art units • 2 examiners • 0 of 2 (0%) have an AI response strategy ready • 1 patents granted in the last 365 days
Lateral Ip Pty Ltd. is prosecuting applications in the Biotechnology & Pharmaceuticals technology area. The portfolio has 2 pending office actions. These actions are handled by 2 distinct examiners. All prosecution activity is situated within 1 distinct art unit. This indicates that while the company is dealing with multiple examiners, the technical focus of the applications is unified within a single department.
The busiest examiner is STEELE, AMBER D, who is responsible for 1 pending office action. This 1 action is part of the 2 total pending office actions for the company. Because there are 2 distinct examiners in 1 distinct art unit, practitioners must navigate two different examiner perspectives on similar technical subject matter. The reliance on 1 art unit suggests a specialized focus, but the involvement of STEELE, AMBER D and another examiner means that prosecution results may vary based on individual examiner interpretation. The 2 pending actions represent the entire active workload.
Based on the USPTO statutory response window for each pending office action. 1 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §112 only | 1 (50%) |
| Double-patenting + other | 1 (50%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| STEELE, AMBER D | 1 | 58.9% | +9.3% |
| REYNOLDS, FRED H | 1 | 33.0% | +39.2% |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17788845 | CYCLIC PEPTIDE RECEPTOR LANTHIONINE SYNTHETASE C-LIKE PROTEIN (LANCL) AND USES THEREOF | REYNOLDS, FRED H | 70d |
| Art Unit | Apps |
|---|---|
| 1658 | 2 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18559118 | COMPOSITIONS FOR TREATING INFLAMMATORY AIRWAY DISEASE AND USES THEREOF | STEELE, AMBER D | 1658 | §102§103DP | Non-Final OA | — | Pending | Nov 06, 2023 |
| 17788845 | CYCLIC PEPTIDE RECEPTOR LANTHIONINE SYNTHETASE C-LIKE PROTEIN (LANCL) AND USES THEREOF | REYNOLDS, FRED H | 1658 | §112Other | Final Rejection | 70d | Pending | Jun 24, 2022 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial